These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10706191)

  • 21. Clinical pharmacokinetics of nicotine.
    Svensson CK
    Clin Pharmacokinet; 1987 Jan; 12(1):30-40. PubMed ID: 3545615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans.
    Gwilt PR; Nahhas RR; Tracewell WG
    Clin Pharmacokinet; 1991 Jun; 20(6):477-90. PubMed ID: 2044331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics.
    Yang Z; Zadjura L; D'Arienzo C; Marino A; Santone K; Klunk L; Greene D; Lin PF; Colonno R; Wang T; Meanwell N; Hansel S
    Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender differences in pharmacokinetics and pharmacodynamics.
    Beierle I; Meibohm B; Derendorf H
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):529-47. PubMed ID: 10584975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Species similarities and differences in pharmacokinetics.
    Lin JH
    Drug Metab Dispos; 1995 Oct; 23(10):1008-21. PubMed ID: 8654187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic optimisation of therapy with beta-adrenergic blocking agents.
    Frishman WH; Lazar EJ; Gorodokin G
    Clin Pharmacokinet; 1991 Apr; 20(4):311-8. PubMed ID: 1674683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
    Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA
    Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.
    De Paepe P; Belpaire FM; Buylaert WA
    Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of human pharmacokinetics--gut-wall metabolism.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1335-43. PubMed ID: 17910807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacokinetics of atorvastatin.
    Lennernäs H
    Clin Pharmacokinet; 2003; 42(13):1141-60. PubMed ID: 14531725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of diet, aging and disease-states on presystemic elimination and oral drug bioavailability in humans.
    Wilkinson GR
    Adv Drug Deliv Rev; 1997 Sep; 27(2-3):129-159. PubMed ID: 10837555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.
    Anderson GD
    Clin Pharmacokinet; 2005; 44(10):989-1008. PubMed ID: 16176115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interethnic differences in pharmacokinetics of antibacterials.
    Tsai D; Jamal JA; Davis JS; Lipman J; Roberts JA
    Clin Pharmacokinet; 2015 Mar; 54(3):243-60. PubMed ID: 25385446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of chirality on pharmacokinetics and pharmacodynamics.
    Crom WR
    Am J Hosp Pharm; 1992 Sep; 49(9 Suppl 1):S9-14. PubMed ID: 1530005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ethnic factors in evaluation of drug efficacy and safety].
    Yasuhara H
    Nihon Yakurigaku Zasshi; 1994 Aug; 104(2):67-78. PubMed ID: 7927070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapeutic disparities: racial, ethnic, and sex variations in medication treatment.
    Hall-Lipsy EA; Chisholm-Burns MA
    Am J Health Syst Pharm; 2010 Mar; 67(6):462-8. PubMed ID: 20208053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics of chiral drugs].
    Bernareggi A
    Boll Chim Farm; 1995 Feb; 134(2):63-8. PubMed ID: 7598834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic changes during pregnancy and their clinical relevance.
    Loebstein R; Lalkin A; Koren G
    Clin Pharmacokinet; 1997 Nov; 33(5):328-43. PubMed ID: 9391746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).
    Besunder JB; Reed MD; Blumer JL
    Clin Pharmacokinet; 1988 Apr; 14(4):189-216. PubMed ID: 3292100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.